معرفی
Betsy Schulman is an Associate Research Scientist in the Department of Neurology at Yale School of Medicine, where she has been conducting research since completing her PhD in 2006. She is affiliated with the Center for Neuroscience and Regeneration Research, focusing on the genetics of neuropathic pain conditions.
Dr. Schulman earned her BFA in Ceramics from the University of Michigan (1997), followed by an MS in Basic Medical Science from Wayne State University School of Medicine (1999), and completed her PhD in Molecular, Cellular, and Developmental Biology at Yale University (2007). She also completed post-doctoral training at Yale University School of Medicine in 2010.
Her research primarily investigates the genetic basis of neuropathic pain, with particular focus on sodium channel mutations associated with conditions like erythromelalgia and ocular pain disorders. She employs approaches including genomic analysis, electrophysiology, and functional profiling to understand pain mechanisms and identify potential therapeutic targets. Her work bridges basic science with clinical applications, exploring how genetic variants influence pain perception and treatment response.
Analysis of Dr. Schulman's recent publications reveals a consistent focus on sodium channelopathies in pain disorders, particularly Nav1.7 and related channels. Her research spans from basic molecular mechanisms to clinical applications, with increasing emphasis on personalized approaches to pain management based on genetic profiling. A notable trend is her investigation of pain resilience mechanisms alongside pain susceptibility.
Outside her primary research role, Dr. Schulman serves as Managing Editor of the scientific journal The Neuroscientist, contributing to scientific communication in the neuroscience field.
Her collaborative work spans multiple institutions, with frequent co-authorship with prominent researchers including Stephen Waxman, Sulayman Dib-Hajj, and Mark Estacion. Her research is supported through various institutional mechanisms at Yale and the VA Connecticut Healthcare System.